"Impact of Extended Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion on Hemodynamics, Vasoactive Substance Requirement, and Pulmonary Oxygenation in Patients with Sepsis: An Observational Study." Mitaka C et al. Blood Purif (Apr 28, 2021 online)
"Unsatisfactory Short-Term Neurodevelopmental Outcomes of Preterm Infants Who Received Polymyxin B-Immobilized Fiber Column-Direct Hemoperfusion for Septic Shock." Nishizaki N et al. Tohoku J. Exp. Med (2021) 253:275-81
"Effects of Polymyxin B Hemoperfusion in Patients with Sepsis Requiring Continuous Hemodiafiltration: Analysis of a Nationwide Administrative Database in Japan." Fujimori K et al. Ther Apher Dial (Apr 22, 2021 online)
"Polymyxin B hemoperfusion therapy and extracorporeal CO2 removal in a patient with COVID-19: A case report." Luca M et al. Case Rep Int (2021) 10:100093Z06ML2021.
"Endotoxin Adsorbent Therapy in Severe COVID-19 Pneumonia." Peerapornratana S et al. Blood Purif (Apr 15, 2021 online)
"Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock." Mitaka C et al. Acute Crit Care (2021) 36:85-91
"Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion." Leelayuwatanakul N et al. Respirol Case Rep (2021) 9:e0733
"Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock." Shoji H et al. Int J Mol Sci (2021) 22:2228
"Uncertain Clinical Effect of Polymyxin B Hemoperfusion in Patients with Septic Acute Kidney Injury Requiring Continuous Renal Replacement Therapy." Lee JM et al. Shock (Feb 17, 2021 online)
"Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan."Fujimori K et al. Blood Purification (Feb 12, 2021 online)
"Polymyxin B hemoperfusion in COVID‐19 Patients with endotoxic shock: Case Series from EUPHAS II registry." De Rosa S et al. Artif Organs (Dec 30. 2020 online)
"Case Report: Successful Use of Extracorporeal Therapies After ECMO Resuscitation in a Pediatric Kidney Transplant Recipient." Rybalko A et al. Front Pediatr (2020) 8:593123
"Damage Control Management of Perforating Pyometra Presenting with Septic Shock after the Return of Spontaneous Circulation." Takamatsu J et al. Case Rep Med (2020) 2020:8545232
"Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID‐19." Ishiwari M et al. Respirol Case Rep (2020) 8:e00679
"Effect of Extracorporeal Blood Purification on Mortality in Sepsis: A Meta-Analysis and Trial Sequential Analysis." Show TAC et al. Blood Purif (Oct 28, 2020 online)
"Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis." Li X et al. J Crit Care (2021) 63:187-95
"Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion." Kusaba Y et al. Intern Med (2020) 59:2405-08
"Treatment of Pyonephritis Complicated by Septic Shock Using Extracorporeal Device Polymyxin B-Hemoperfusion." Amoruso G et al. Blood Purif (2020) 49:627-30
"Intensive care management of a patient with necrotizing fasciitis due to non-O1/O139 Vibrio cholerae after traveling to Taiwan: a case report." Tsuruta K et al. BMC Infectious Diseases (2020) 20:618
"A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post–kidney transplant recipient." Thammathiwat et al. Transpl Infect Dis (2020) 00:e13388
"Initial Experience of Using Polymyxin B Hemoperfusion in Abdominal Septic Shock: Things to Consider for Better Outcome." Park YJ et al. J Acute Care Surg (2020) 10:13-7
"Effects of endotoxin adsorber hemoperfusion on sublingual microcirculation in patients with septic shock: a randomized controlled trial." Chen SH et al. (2020) Ann Intensive Care 10:80
"Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM." Yamato M et al. Ther Apher Dial (2020) 24:492-8
"Beneficial Effect Modification on Survival Outcome of Sepsis Between ART-123 and Polymyxin
B‑immobilised Haemoperfusion: A Nationwide Japanese Registry Study" Mochizuki K et al. Ann
Intensive Care (2020) 10:57
"Septicemia, Necrotizing Fasciitis, and Peritonitis Due to Vibrio Vulnificus Treated With Early
Use of Polymyxin B Hemoperfusion in a Patient Undergoing CAPD: A Case Report." Kim JY et al. BMC
Nephrol (2020) 21:127
"Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating
Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic
Septic Shock (EUPHRATES) Trial."
Rachoin JS et al. Crit Care Expl (2020) 2:e0083
"Successful treatment of direct hemoperfusion with polymyxin B immobilized fiber for septic
shock and severe acute kidney injury due to ceftriaxone-resistant Escherichia coli: a case report with
literature review."
Shima H et al. Renal Replacement Ther (2020) 6:16
"Identifying Septic Shock Populations Benefitting from Polymyxin B Hemoperfusion: A Prospective
Cohort Study Incorporating a Restricted Cubic Spline Regression Model."
Nakata H et al. Shock (2020) 54:667-74
"Clinical effects of polymyxin B-immobilized fiber column direct hemoperfusion for severe
bacterial meningitis: A series of 10 cases."
Suzuki Y et al. Clin Case Rep (2020) 8:823-32
"Could There Be a Biologically Plausible Niche for Polymyxin B-Immobilized Fiber Column Direct
Hemoperfusion Treatment in Early Onset Neonatal Septic Shock?" Aldewereld Z et al. Pediatr Crit Care
Med (2020) 21:202-3
"Sequential Extracorporeal Therapy Collaborative Device and Timely Support for Endotoxic,
Septic, and Cardiac Shock: A Case Report."De Rosa S et al. Blood Purif (2020) 49:502-98
"Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic
shock."Kim JJ et al. World J Gastrointest Surg (2019) 11:422-32
"Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan."Fujimori K et al. Blood Purification (Feb 12, 2021 online)
"Effects of endotoxin adsorber hemoperfusion on sublingual microcirculation in patients with septic shock: a randomized controlled trial." Chen SH et al. (2020) Ann Intensive Care 10:80
"Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a
post hoc analysis of the EUPHRATES trial." Klein DJ et al. Intensive Care Med (2018) Nov. 23
"The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe
sepsis patients." Srisawat N et al. Crit Care (2018) 22:279
"Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock
and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.." Dellinger RP et al. JAMA
(2018) 320:1455-63
"Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with
sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis." Fujii
T et al. Intensive Care Med (2018) 44:167-78
"Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a
propensity-matched cohort study." Nakamura Y et al. Crit Care (2017) 21:134
"Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic
Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis."
Chang T et al. Crit Care Med (2017) 45:e858-e864
"Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous
Renal Replacement Therapy: A Propensity-Matched Analysis." Iwagami M et al. Blood Purif (2016)
42:9-17
"Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a
multicenter randomized control trial." Payen D et al. Intensive Care Med (2015) 41:975-84
"Rescue therapy with Polymyxin B hemoperfusion in high dose vasopressor therapy Refractory
Septic Shock." Monti G et al. Minerva Anestesiol (2015) 81:516-2
"Endotoxin adsorption using polymyxin B immobilized fiber cartridges in severe sepsis patients
following cardiac surgery." Yaroustovsky M et al. Int J Artif Organs (2014) 37:299-307
"Postoperative Polymyxin B Hemoperfusion and Mortality in Patients With Abdominal Septic Shock:
A Propensity-Matched Analysis." Iwagami M et al. Crit Care Med (2013) 42:1187-93
"A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with
severe sepsis secondary to intra-abdominal Infection." Vincent JL et al. Shock (2005) 23:400-5
“Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock.” Mitaka C et al. Acute Crit Care (2021) 36:85-91
"Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock." Shoji H et al. Int J Mol Sci (2021) 22:2228
"Evidence and Perspectives on the Use of Polymyxin B-Immobilized Fiber Column Hemoperfusion among
Critically Ill Patients." Yamashita C et al. Contrib Nephrol (2018) 196:215-22
"History and current status of polymyxin B-immobilized fiber column for treatment of severe
sepsis and septic shock" Shimizu T et al. Ann Gastroenterol Surg (2017) 2017:1–9
"Immunomodulation in Sepsis: The Role of Endotoxin Removal by Polymyxin B-Immobilized
Cartridge." Esteban E et al. Mediators Inflamm (2013) 2013:507539
